DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine
- Jingxin Ye 1,2,3, Jianfeng Zhang 2, Weifeng Ding 1
- Jingxin Ye 1,2,3, Jianfeng Zhang 2, Weifeng Ding 1
- 1Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
- 2Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
- 3Department of Gastroenterology, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian 223800, Jiangsu Province, China.
- 0Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.DNA methylation is crucial in colorectal cancer (CRC) development and progression. Understanding these epigenetic changes can improve CRC diagnosis, prognosis, and personalized treatment strategies for better patient outcomes.
Area Of Science
- Oncology
- Epigenetics
- Molecular Biology
Background
- Colorectal cancer (CRC) exhibits significant clinical heterogeneity.
- Genetic and environmental factors alone do not fully explain CRC's complexity.
- Epigenetic modifications, particularly DNA methylation, are recognized as critical molecular markers in cancer.
Purpose Of The Study
- To review the extensive evidence on DNA methylation's role in colorectal cancer pathogenesis.
- To explore the diagnostic, prognostic, and therapeutic predictive potential of DNA methylation in CRC.
- To highlight how understanding DNA methylation advances precision medicine for CRC.
Main Methods
- Comprehensive literature review.
- Synthesis of existing research on DNA methylation in CRC.
- Analysis of studies investigating methylation's clinical utility.
Main Results
- DNA methylation modifications are significantly involved in the development and progression of CRC.
- DNA methylation serves as a key molecular marker with potential applications in CRC management.
- Evidence supports the utility of DNA methylation in diagnosing CRC, predicting prognosis, assessing disease activity, and guiding drug response.
Conclusions
- DNA methylation plays a pivotal role in the pathogenesis of colorectal cancer.
- Epigenetic markers like DNA methylation offer promising avenues for improving CRC diagnosis and patient stratification.
- Leveraging DNA methylation insights can facilitate personalized treatment strategies and advance precision oncology in CRC management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

